ArticleYonsei medical journal2022

Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy.

Zhipeng Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.